Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Life Sci ; 215: 207-215, 2018 Dec 15.
Article En | MEDLINE | ID: mdl-30439377

AIMS: The aim of this study was to evaluate gamma-aminobutyric acid (GABA)- and piperine-induced erythropoietin (EPO) and EPO-receptor expression. MATERIALS AND METHODS: The effect of GABA and piperine on cell viability was examined using kidney epithelial cells. Expression levels of EPO and EPO-R mRNA and protein were evaluated in response to GABA and piperine treatments. GABA- and piperine-mediated activation of the mitogen-activated protein kinase (MAPK) signaling pathway was investigated. Additionally, EPO function was evaluated using conditioned media containing EPO. The GABA receptor type involved in this process was identified. KEY FINDINGS: Messenger RNA and protein expression levels of EPO and EPO-R significantly increased in response to treatment with GABA, piperine, or the combination of both, compared with control. GABA plus piperine synergistically enhanced EPO and EPO-R expression through p38 and c-Jun N-terminal kinase (JNK) MAPK signaling pathways, but not through the extracellular signal-regulated kinase (ERK) MAPK pathway. SB203580 and SP600125 (p38 and JNK pathway inhibitors, respectively) attenuated GABA plus piperine-induced EPO and EPO-R expression. Treatment of macrophages with EPO-containing conditioned media induced mRNA expression of interleukin (IL)-10 and nuclear factor (NF)-κB due to the interaction between EPO and EPO-R. Interestingly, GABA-induced EPO and EPO-R expression was mediated through GABAA, not GABAB, receptor activation. SIGNIFICANCE: These findings demonstrate that GABA plus piperine-mediated p38 and JNK MAPK activation increases EPO and EPO-R expression, resulting in up-regulation of IL-10 and NF-κB.


Alkaloids/pharmacology , Benzodioxoles/pharmacology , Cell Survival/drug effects , Erythropoietin/genetics , Piperidines/pharmacology , Polyunsaturated Alkamides/pharmacology , Receptors, Erythropoietin/genetics , gamma-Aminobutyric Acid/pharmacology , Alkaloids/administration & dosage , Animals , Benzodioxoles/administration & dosage , Cell Line , Drug Synergism , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Gene Expression Regulation/drug effects , Interleukin-10/genetics , Kidney/drug effects , Kidney/metabolism , LLC-PK1 Cells , MAP Kinase Signaling System/drug effects , NF-kappa B/genetics , Piperidines/administration & dosage , Polyunsaturated Alkamides/administration & dosage , RNA, Messenger/metabolism , Swine , Up-Regulation/drug effects , gamma-Aminobutyric Acid/administration & dosage
2.
Int J Biol Macromol ; 117: 1147-1156, 2018 Oct 01.
Article En | MEDLINE | ID: mdl-29870812

Hormesis is a dose-response phenomenon that, when applied to nanomaterial-biological interactions, refers to growth stimulation at low doses and growth inhibition at high doses. MUDENG (Mu-2-related death-inducing gene, MuD) is involved in cell death signaling. Astrocytes, the major glial cell type in the central nervous system, are a major source of brain tumors. In this study, we investigated whether silver nanoparticles (AgNPs) induce hormesis in astroglioma cells and the possible involvement of MuD in AgNP-induced hormesis. AgNPs exhibited cytotoxic effects on cell proliferation in a dose-dependent manner and increased MuD expression was observed during AgNP-induced astroglioma hormesis. Studies using MuD-knockout cells and MuD siRNA transfection showed that MuD might influence cell viability upon AgNP treatment. In addition, apoptotic cell population and production of reactive oxygen species in the absence of MuD were significantly increased. The phosphorylation of two mitogen-activated protein kinases, p38 and extracellular signal-regulated kinase (ERK), but not c-Jun N-terminal kinases (JNK), was observed upon AgNP stimulation. In summary, AgNPs at low doses induced hormesis of human astroglioma cells, and MuD and p38/ERK mediators are involved in AgNP-induced astroglioma hormesis, resulting in beneficial effects from the cellular point of view.


Astrocytoma/drug therapy , Astrocytoma/metabolism , Hormesis/drug effects , Metal Nanoparticles/adverse effects , Metal Nanoparticles/chemistry , Silver , Astrocytoma/genetics , Biomarkers , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Humans , Metal Nanoparticles/ultrastructure , Mitogen-Activated Protein Kinases/metabolism , Reactive Oxygen Species/metabolism , Silver/adverse effects , Silver/chemistry , Spectrophotometry, Ultraviolet , p38 Mitogen-Activated Protein Kinases/metabolism
...